Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 475 of 1,261

  1. US 10406248

    Molecular imaging of cancer cells in vivo

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  2. US 10406241

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  3. US 10406233

    Telodendrimers with enhanced drug delivery

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  4. US 10406222

    Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  5. US 10406210

    High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

    Amphastar Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  6. US 10406177

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  7. US 10406214

    Propionyl-CoA carboxylase compositions and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  8. US 10406167

    Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

    The Board of Regents of the University of Texas System · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  9. US 10406157

    Tetrahydropyridopyrazine modulators of GPR6

    Takeda Pharmaceutical Company Limited · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  10. US 10406146

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  11. US 10406160

    Sustained release small molecule drug formulation

    Indivior UK Limited · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  12. US 10405560

    Method for making coffee products containing cannabis ingredients

    Blacklist Holdings, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  13. US 10407735

    Schlap-1 ncRNA and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  14. US 10407697

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  15. US 10407680

    Compounds and methods for reducing Tau expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  16. US 10407679

    Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  17. US 10406148

    Methods of treatment using a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  18. US 10407443

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  19. US 10406226

    Method of manufacturing VEGF antagonist fusion proteins

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  20. US 10408834

    Mutated parvovirus structural proteins as vaccines

    Ludwig-Maximilians-Universitat Munchen · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  21. US 10407392

    Antifungal compound process

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  22. US 10406158

    Methods and compositions for treating abnormal cell growth

    VERASTEM, INC. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  23. US 10407409

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  24. US 10406169

    Methods of monitoring estriol therapy

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.